54 results
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
customers by product and by geographic region, based on the location of the customer.
Three months ended September 30, 2022 (unaudited)
U.S.
EMEA … , 2022, one customer accounted for 47% and 45% of the Group’s net revenues (2021: 47% and 48%) and accounted for 40% of the Group’s September 30, 2022
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
. The following table summarizes total revenues from external customers by product and by geographic region, based on the location of the customer.
Three …
Total
US$’000
Metreleptin
Lomitapide
Mycapssa®
Other
Total revenue
Major Customers
For the three and six months ended June 30, 2022, one customer
6-K
EX-99.2
AMYT
Amryt Pharma Plc
11 May 22
Current report (foreign)
4:30pm
receivable. During the six months ended June, 2021, one customer comprised greater than 90% of our accounts receivable and product revenues.
We … such costs will be amortized.
Revenue Recognition
In accordance with accounting guidance for revenue recognition, we recognize revenue when a customer
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
8:35am
summarizes total revenues from external customers by product and by geographic region, based on the location of the customer.
Three months ended March 31 … customer accounted for 48% of the Group’s net revenues (March 31, 2021: 51%) and accounted for 36% of the Group’s March 31, 2022, accounts receivable
424B3
AMYT
Amryt Pharma Plc
4 May 22
Prospectus supplement
7:45am
summarizes total revenues from external customers by product and by geographic region, based on the location of the customer.
Three months ended March 31 … customer accounted for 48% of the Group’s net revenues (March 31, 2021: 51%) and accounted for 36% of the Group’s March 31, 2022, accounts receivable
6-K
EX-99.1
e06 entivod
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am
424B3
88i9a02jofh0
9 Mar 22
Prospectus supplement
9:26am
424B3
407ue8 tla
9 Mar 22
Prospectus supplement
9:25am
6-K
EX-99.1
wmd3enn0v
9 Mar 22
Amryt Announces 22% growth in FY 2021 Revenues to $222.5M
9:23am
6-K
EX-99.1
fxhdwvv
25 Feb 22
Current report (foreign)
4:05pm
424B3
efd5wuwd30
3 Nov 21
Prospectus supplement
7:33am
424B3
hjckeei
3 Nov 21
Prospectus supplement
7:32am
6-K
EX-99.1
gbu6gry1
3 Nov 21
Amryt Reports Strong Q3 2021 Results
7:31am
6-K
EX-99.2
025hmzdobkqjopj94tf9
13 Sep 21
Current report (foreign)
8:48am
6-K
EX-99.1
chzzfm9wzc
6 Aug 21
Amryt Reports Record Q2 2021 Results and Raises FY 2021 Guidance
8:18am